Results 21 to 30 of about 421,690 (259)

Speaker Diarization Based on Intensity Channel Contribution [PDF]

open access: yes, 2011
The time delay of arrival (TDOA) between multiple microphones has been used since 2006 as a source of information (localization) to complement the spectral features for speaker diarization.
J M Montero   +7 more
core   +1 more source

Optimization of the flat plate dynamic speaker of design parameters by experimental approach

open access: yesNihon Kikai Gakkai ronbunshu, 2016
This study tried optimization of design parameter of an ultra-thin flat plate dynamic speaker unit as an example of high flexibility of the products design.
Tomoaki HIDAKA   +3 more
doaj   +1 more source

EMPHATIC APOLOGY IN GERMAN LINGUACULTURE [PDF]

open access: yesВісник університету ім. А. Нобеля. Серія Філологічні науки, 2019
In the proposed article, apology is considered as a speech genre (hereinafter SG), which is a set of lingua-pragmatic meanings typical of the implementation of apology in German.
Oleksandra M. Shumiatska
doaj   +1 more source

A Hybrid Parameterization Technique for Speaker Identification [PDF]

open access: yes, 2008
Classical parameterization techniques for Speaker Identification use the codification of the power spectral density of raw speech, not discriminating between articulatory features produced by vocal tract dynamics (acoustic-phonetics) from glottal source ...
Rodellar Biarge, M. Victoria   +15 more
core   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani   +7 more
wiley   +1 more source

Unsupervised Intralingual and Cross-Lingual Speaker Adaptation for HMM-Based Speech Synthesis Using Two-Pass Decision Tree Construction [PDF]

open access: yes, 2010
Hidden Markov model (HMM)-based speech synthesis systems possess several advantages over concatenative synthesis systems. One such advantage is the relative ease with which HMM-based systems are adapted to speakers not present in the training dataset ...
Matthew Gibson, William Byrne
core   +2 more sources

Social Functioning Within the First Years After Pediatric Brain Tumor Diagnosis and the Relationship With Family Psychosocial Risk

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survivors of pediatric brain tumors (PBTs) can experience long‐term social difficulties, impacting quality of life. Beyond medical and environmental factors, family psychosocial risk may play a role in social outcomes by shaping the caregiving environment and may provide intervention options.
Renske H. Houben   +4 more
wiley   +1 more source

Biologically inspired speaker verification [PDF]

open access: yes, 2012
Speaker verification is an active research problem that has been addressed using a variety of different classification techniques. However, in general, methods inspired by the human auditory system tend to show better verification performance than other ...
Tashan, T
core  

A Piezoelectric MEMS Speaker with a Combined Function of a Silent Alarm

open access: yesMicromachines, 2023
To explore the versatility of speakers, a piezoelectric micro-electro-mechanical system (MEMS) speaker combining the function of a silent alarm is proposed, which mainly comprises a lead zirconate titanate (PZT) actuation layer and a rigid–flexible ...
Qi Wang   +7 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy